Lecicarbon S Co2-Laxans

Sodium hydrogen carbonate and sodium dihydrogen phosphate, the active ingredients in Lecicarbon S Co2-Laxans, are excipient/buffer agents presented as a rectal preparation for rectal use. They facilitate bowel movements and are employed in the management of constipation and bowel cleansing.

GNH USA supplies Lecicarbon S Co2-Laxans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, ensuring timely delivery and regulatory compliance throughout.

Lecicarbon S Co2-Laxans is used as a rectal laxative to promote bowel evacuation.

- Constipation: facilitates stool softening and promotes evacuation in patients with functional constipation. - Bowel preparation for colonoscopy: aids in cleansing the colon prior to diagnostic procedures. - Enema administration: provides buffering action to reduce discomfort during rectal enema use.

Lecicarbon S Co2-Laxans may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramping - Rectal irritation - Flatulence - Nausea - Mild diarrhea - Transient discomfort during administration

Serious or Rare Side Effects: - Severe abdominal pain - Rectal bleeding - Allergic reaction (rash, itching, swelling) - Electrolyte imbalance - Severe dehydration - Rare cases of mucosal ulceration

When using Lecicarbon S Co2-Laxans, consider the following precautions.

- Assess patient history: verify absence of intestinal obstruction before use. - Avoid in patients with inflammatory bowel disease flare-ups: risk of exacerbation. - Monitor fluid balance: ensure adequate hydration during treatment. - Use with caution in elderly: increased sensitivity to rectal irritation. - Pregnancy and lactation: consult healthcare professional before administration. - Store below 25°C: keep in original packaging, protect from moisture.

Potential drug interactions should be reviewed prior to administration.

Major Interactions (Avoid): - Concurrent use with high‑dose oral sodium bicarbonate: risk of systemic alkalosis. - Co‑administration with potassium‑sparing diuretics: potential electrolyte disturbances. - Use with rectal irritants (e.g., phenolphthalein): increased mucosal irritation.

Moderate Interactions (Monitor Closely): - Combination with anticholinergic agents: may reduce laxative efficacy. - Concurrent use with other osmotic laxatives: monitor for excessive fluid loss. - Interaction with anticoagulants: monitor for rectal bleeding risk.